We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current OPK market cap is 878.21M. The company's latest EPS is USD -0.2710 and P/E is -4.69.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 180.43M | 185.97M | 237.58M | 265.42M | 179.62M |
| Operating Income | -87.89M | -58.46M | -30.59M | 6.89M | -64.41M |
| Net Income | -86.09M | -85.23M | -18.27M | -19.64M | -84.47M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 916.79M | 1.44B | 1.78B | 1.01B | 864.53M |
| Operating Income | -207.88M | 57.71M | -12.76M | -244.81M | -157.02M |
| Net Income | -314.93M | 30.59M | -30.14M | -328.41M | -188.86M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 2.22B | 2.17B | 2.17B | 2.16B | 2.06B |
| Total Liabilities | 595.72M | 605.61M | 617.86M | 623.55M | 612.11M |
| Total Equity | 1.63B | 1.56B | 1.55B | 1.54B | 1.44B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 2.31B | 2.47B | 2.4B | 2.17B | 2.01B |
| Total Liabilities | 694.51M | 801.51M | 714.59M | 605.61M | 622.48M |
| Total Equity | 1.61B | 1.67B | 1.69B | 1.56B | 1.39B |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -63.57M | -95.19M | -22.65M | -23.01M | 10.1M |
| Investing | 98.91M | 91.04M | -7.72M | -13.21M | -16.78M |
| Financing | 12.83M | 22.97M | -13.12M | -9.66M | -7.55M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -172.52M | 39.48M | 38.34M | -95.19M | -28.2M |
| Investing | -13.27M | -18.33M | 35.95M | 91.04M | -18.2M |
| Financing | 175.25M | -35.08M | -10.35M | 22.97M | -11.3M |
| Market Cap | 878.21M |
| Price to Earnings Ratio | -4.69 |
| Price to Sales Ratio | 1.02 |
| Price to Cash Ratio | 9.23 |
| Price to Book Ratio | 0.64 |
| Dividend Yield | - |
| Shares Outstanding | 696.99M |
| Average Volume (1 week) | 4.01M |
| Average Volume (1 Month) | 5.52M |
| 52 Week Change | -14.86% |
| 52 Week High | 2.24 |
| 52 Week Low | 0.8516 |
| Spread (Intraday) | 0.01 (0.79%) |
| Company Name | Opko Health Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.opko.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
